| American Regent, Inc. v. Hikma Pharms. USA Inc., 25-2224 (D.N.J.) |
Apr. 1, 2025 |
Hon. Brian R. Martinotti |
Tralement®
(trace elements zinc sulfate / cupric sulfate /
manganese sulfate / selenious acid injection) |
11,786,548
11,975,022
11,998,565
12,150,956
12,150,957 |
| Merck Sharp & Dohme B.V. v. Xiromed Pharma España, S.L., 25-2254 (D.N.J.) |
Apr. 2, 2025 |
Hon. Claire C. Cecchi |
Nexplanon®
(etonogestrel implant) |
8,722,037
9,757,552 |
| Urovant Sciences GmbH v. Annora Pharma Private Ltd., 25-0419 (D. Del.) |
Apr. 3, 2025 |
Hon. Gregory B. Williams |
Gemtesa®
(vibegron tablets) |
12,102,638 |
| Urovant Sciences GmbH v. MSN Labs. Private Ltd., 25-0420 (D. Del.) |
Apr. 3, 2025 |
Hon. Gregory B. Williams |
Gemtesa®
(vibegron tablets) |
12,102,638 |
| AbbVie Inc. v. Aurobindo Pharma USA, Inc., 25-0422 (D. Del.) |
Apr. 4, 2025 |
Hon. Maryellen Noreika |
Rinvoq®
(upadacitinib extended-release tablets) |
RE47,221 |
| Melinta Therapeutics, LLC v. Gland Pharma Ltd., 25-3676 (N.D. Ill.) |
Apr. 4, 2025 |
Hon. Jeremy C. Daniel |
Minocin®
(minocycline injection) |
9,278,105
9,084,802
11,944,634
12,161,656 |
| Salix Pharms., Inc. v. SABA Ilac Sanayi ve Ticaret A.S., 25-2307 (D.N.J.) |
Apr. 4, 2025 |
Hon. John F. Murphy |
Xifaxan®
(rifaximin tablets) |
11,564,912
11,779,571
8,193,196
7,928,115 |
| Exelixis, Inc. v. Sun Pharm. Indus. Ltd., 25-0423 (D. Del.) |
Apr. 4, 2025 |
Hon. Richard G. Andrews |
Cabometyx®
(cabozantinib tablets) |
12,128,039 |
| Pfizer Inc. v. Annora Pharma Private Ltd., 25-0424 (D. Del.) |
Apr. 4, 2025 |
Hon. Colm F. Connolly |
Xeljanz®
(tofacitinib tablets) |
RE41,783 |
| Hetero Labs Ltd. v. AbbVie Inc., 25-0431 (D. Del.) |
Apr. 7, 2025 |
Hon. Jennifer L. Hall |
Orilissa®
(elagolix sodium tablets) |
12,102,637 |
| Aurinia Pharms. Inc. v. Hikma Pharms. USA Inc., 25-2580 (D.N.J.) |
Apr. 10, 2025 |
Hon. Jamel K. Semper |
Lupkynis®
(voclosporin capsules) |
10,286,036
11,622,991 |
| Ascendis Pharma A/S v. BioMarin Pharm. Inc., 25-3302 (N.D. Cal.) |
Apr. 11, 2025 |
Hon. Joseph C. Spero |
Voxzogo®
(vosoritide injection) |
RE48,267 |
| Merck Sharp & Dohme LLC v. Aurobindo Pharma Ltd., 25-0449 (D. Del.) |
Apr. 11, 2025 |
Hon. Richard G. Andrews |
Janumet XR®
(metformin HCl / sitagliptin phosphate extended-release tablets) |
7,326,708 |
| Aurinia Pharms. Inc. v. Lotus Pharm. Co., Ltd., 25-2613 (D.N.J.) |
Apr. 11, 2025 |
Hon. Jamel K. Semper |
Lupkynis®
(voclosporin capsules) |
10,286,036
11,622,991 |
| American Regent, Inc. v. Amneal Pharms. of NY, LLC, 25-2642 (D.N.J.) |
Apr. 11, 2025 |
Hon. Brian R. Martinotti |
Tralement®
(trace elements zinc sulfate / cupric sulfate /
manganese sulfate / selenious acid injection) |
11,786,548
11,975,022
11,998,565
12,150,956
12,150,957 |
| Vertex Pharms. Inc. v. Lupin Ltd., 25-0450 (D. Del.) |
Apr. 11, 2025 |
Hon Richard G. Andrews |
Kalydeco®
(ivacaftor granules) |
8,883,206
10,272,046
10,646,481
11,147,770
11,564,916
11,752,106
12,214,083 |
| Exelixis, Inc. v. Biocon Pharma Ltd., 25-0452 (D. Del.) |
Apr. 11, 2025 |
Hon Richard G. Andrews |
Cabometyx®
(cabozantinib(S)-malate tablets) |
8,877,776
11,091,439
11,091,440
11,098,015
12,128,039 |
| Veloxis Pharms., Inc. v. Glenmark Pharms. Inc., 25-0458 (D. Del.) |
Apr. 14, 2025 |
Hon. Maryellen Noreika |
Envarsus XR®
(tacrolimus extended-release tablets) |
8,685,998
9,549,918
10,166,190
10,864,199
11,110,081
11,123,331
11,419,823
12,083,103 |
| Jazz Pharms., Inc. v. Almaject, Inc., 25-2785 (D.N.J.) |
Apr. 16, 2025 |
Hon. Stanley R. Chesler |
Defitelio®
(defibrotide sodium injection) |
11,085,043
11,236,328
11,746,348 |
| Aurinia Pharms. Inc. v. Galenicum Health S.L.U., 25-2807 (D.N.J.) |
Apr. 17, 2025 |
Hon. Jamel K. Semper |
Lupkynis®
(voclosporin capsules) |
10,286,036
11,622,991 |
| Aragon Pharms., Inc. v. Lupin Ltd., 25-2860 (D.N.J.) |
Apr. 18, 2025 |
Hon. Stanley R. Chesler |
Erleada®
(apalutamide tablets) |
11,963,952 |
| Fresenius Kabi USA, LLC v. Endo Operations Ltd., 25-2861 (D.N.J.) |
Apr. 18, 2025 |
Hon. Susan D. Wigenton |
levothyroxine sodium injection |
9,782,376
10,398,669
11,135,190 |
| Exelixis, Inc. v. Azurity Pharms., Inc., 25-0478 (D. Del.) |
Apr. 18, 2025 |
Hon. Richard G. Andrews |
Cabometyx®
(cabozantinib (S)-malate tablets) |
8,877,776
11,091,439
11,091,440
11,098,015
11,298,349
12,128,039 |
| Adverio Pharma GmbH v. Changzhou Pharm. Factory, 25-0479 (D. Del.) |
Apr. 18, 2025 |
Hon. Gregory B. Williams |
Verquvo®
(vericiguat tablets) |
8,420,656
8,921,377
9,604,948
9,993,476
10,736,896
11,439,642 |
| Aurinia Pharms. Inc. v. Zydus Pharms. (USA) Inc., 25-2893 (D.N.J.) |
Apr. 21, 2025 |
Hon. Jamel K. Semper |
Lupkynis®
(voclosporin capsules) |
10,286,036
11,622,991 |
| Tris Pharma, Inc. v. Granules Pharms., Inc., 25-0498 (D. Del.) |
Apr. 24, 2025 |
Hon. Jennifer L. Hall |
Dyanavel® XR
(amphetamine extended-release tablets) |
11,590,081 |
| Onyx Therapeutics, Inc. v. Somerset Therapeutics, LLC, 25-0500 (D. Del.) |
Apr. 24, 2025 |
Hon. Gregory B. Williams |
Kyprolis®
(carfilzomib injection) |
7,737,112 |
| Pharmacosmos A/S v. Teva Pharms., Inc., 25-3218 (D.N.J.) |
Apr. 24, 2025 |
Hon. Julien Xavier Neals |
Cosela®
(trilaciclib injection) |
11,529,352
12,168,666 |
| Aurinia Pharms. Inc. v. Teva Pharms., Inc., 25-3267 (D.N.J.) |
Apr. 25, 2025 |
Hon. Jamel K. Semper |
Lupkynis®
(voclosporin capsules) |
10,286,036
11,622,991 |
| Mitsubishi Tanabe Pharma Corp. v. Shanghai Auzone Biological Technology Co., Ltd., 25-3326 (D.N.J.) |
Apr. 25, 2025 |
Hon. Claire C. Cecchi |
Radicava ORS®
(edaravone oral suspension) |
10,987,341
11,241,416
11,478,450
11,826,352
11,957,660 |
| Vifor (Int’l) AG v. MSN Labs. Private Ltd., 25-3286 (D.N.J.) |
Apr. 25, 2025 |
Hon. Georgette Castner |
Injectafer®
(ferric carboxymaltose injection) |
7,612,109
7,754,702
8,895,612
11,364,260
11,433,091
11,478,502 |
| Impax Labs., LLC v. Qilu Pharm. (Hainan) Co., Ltd., 25-3292 (D.N.J.) |
Apr. 25, 2025 |
Hon. Brian R. Martinotti |
Rytary®
(carbidopa / levodopa extended-release capsules) |
8,557,283
9,089,608
9,463,246
9,533,046
9,901,640 |
| Neurocrine Biosciences, Inc. v. Zydus Pharms. (USA) Inc., 25-3354 (D.N.J.) |
Apr. 25, 2025 |
Hon. Karen M. Williams |
Ingrezza® Sprinkle
(valbenazine capsules) |
8,039,627
8,357,697
10,065,952
10,844,058
10,851,103
10,851,104
10,857,137
10,857,148
10,874,648
10,906,902
10,906,903
10,912,771
10,919,892
10,940,141
10,952,997
10,993,941
11,026,931
11,026,939
11,040,029
11,311,532 |
| Neurocrine Biosciences, Inc. v. Zydus Pharms. (USA) Inc., 25-0509 (D. Del.) |
Apr. 25, 2025 |
Hon. Maryellen Noreika |
Ingrezza® Sprinkle
(valbenazine capsules) |
8,039,627
8,357,697
10,065,952
10,844,058
10,851,103
10,851,104
10,857,137
10,857,148
10,874,648
10,906,902
10,906,903
10,912,771
10,919,892
10,940,141
10,952,997
10,993,941
11,026,931
11,026,939
11,040,029
11,311,532 |
| Bausch & Lomb Inc. v. Somerset Therapeutics, LLC, 25-3395 (D.N.J.) |
Apr. 28, 2025 |
Hon. Robert Kirsch |
Lumify®
(brimonidine tartrate ophthalmic solution) |
8,293,742
9,259,425
11,596,600
11,833,245 |
| Boehringer Ingelheim Pharms. Inc. v. Biocon Ltd., 25-0523 (D. Del.) |
Apr. 30, 2025 |
Hon. Colm F. Connolly |
Tradjenta®
(linagliptin tablets) |
8,853,156
9,486,526
10,034,877
11,911,388 |
| Aurinia Pharms. Inc. v. DifGen Pharms. LLC, 25-3533 (D.N.J.) |
Apr. 30, 2025 |
Hon. Jamel K. Semper |
Lupkynis®
(voclosporin capsules) |
10,286,036
11,622,991 |
| Aurinia Pharms. Inc. v. DifGen Pharms. LLC, 25-0530 (D. Del.) |
1-May-25 |
Hon. Jennifer L. Hall |
Lupkynis®
(voclosporin capsules) |
10,286,036
11,622,991 |
| Aurinia Pharms. Inc. v. Dr. Reddy’s Labs., Inc., 25-3693 (D.N.J.) |
1-May-25 |
Hon. Jamel K. Semper |
Lupkynis®
(voclosporin capsules) |
10,286,036
11,622,991 |
| Axsome Malta Ltd. v. Aurobindo Pharma USA, Inc., 25-3721 (D.N.J.) |
1-May-25 |
Hon. Madeline Cox Arleo |
Sunosi®
(solriamfetol tablets) |
12,194,016 |
| Azurity Pharms., Inc. v. Helsinn Healthcare S.A., IPR2025-00945 (PTAB) |
1-May-25 |
N/A |
Akynzeo®
(netupitant / palonosetron HCl capsules) |
8,623,826 |
| Azurity Pharms., Inc. v. Helsinn Healthcare S.A., IPR2025-00946 (PTAB) |
1-May-25 |
N/A |
Akynzeo®
(netupitant / palonosetron HCl capsules) |
9,186,357 |
| Azurity Pharms., Inc. v. Helsinn Healthcare S.A., IPR2025-00947 (PTAB) |
1-May-25 |
N/A |
Akynzeo®
(netupitant / palonosetron HCl capsules) |
9,186,357 |
| Azurity Pharms., Inc. v. Helsinn Healthcare S.A., IPR2025-00948 (PTAB) |
1-May-25 |
N/A |
Akynzeo®
(netupitant / palonosetron HCl capsules) |
9,943,515 |
| Azurity Pharms., Inc. v. Helsinn Healthcare S.A., IPR2025-00949 (PTAB) |
1-May-25 |
N/A |
Akynzeo®
(netupitant / palonosetron HCl capsules) |
10,828,297 |
| Vifor (Int’l) AG v. Orbicular Pharm. Technologies Pvt. Ltd., 25-0540 (D. Del.) |
2-May-25 |
Hon. Colm F. Connolly |
Injectafer®
(ferric carboxymaltose injection) |
7,612,109
7,754,702
8,895,612
11,433,091
11,478,502 |
| Theravance Biopharma R&D IP, LLC v. Eugia Pharma Specialties Ltd., 25-3790 (D.N.J.) |
2-May-25 |
Hon. Karen M. Williams |
Yupelri®
(revefenacin oral inhalation solution) |
12,285,417 |
| Aveo Pharms., Inc. v. Somerset Therapeutics, LLC, 25-0560 (D. Del.) |
7-May-25 |
Hon. Maryellen Noreika |
Fotivda®
(tivozanib HCl capsules) |
11,504,365 |
| Azurity Pharms., Inc. v. Alkem Labs. Ltd., 25-0563 (D. Del.) |
7-May-25 |
Hon. Gregory B. Williams |
Zonisade®
(zonisamide oral suspension) |
11,478,456
11,529,333 |
| Pfizer Inc. v. Alkem Labs. Ltd., 25-0565 (D. Del.) |
7-May-25 |
Hon. Colm F. Connolly |
Xeljanz® XR
(tofacitinib citrate extended-release tablets) |
RE41,783 |
| Pharmacosmos A/S v. Hetero Labs Ltd., 25-3945 (D.N.J.) |
7-May-25 |
Hon. Julien Xavier Neals |
Cosela®
(trilaciclib for injection) |
11,529,352
12,168,666 |
| Pharmacosmos A/S v. Dr. Reddy’s Labs., Inc., 25-3967 (D.N.J.) |
7-May-25 |
Hon. Julien Xavier Neals |
Cosela®
(trilaciclib for injection) |
8,598,186
8,598,197
9,957,276
10,189,849
10,189,850
10,927,120
11,040,042
9,487,530
10,085,992
10,966,984
11,717,523
11,529,352
12,168,666 |
| Aurinia Pharms. Inc. v. Sandoz Inc., 25-3986 (D.N.J.) |
8-May-25 |
Hon. Jamel K. Semper |
Lupkynis®
(voclosporin capsules) |
10,286,036
11,622,991 |
| Incyte Corp. v. Apotex Inc., 25-4044 (D.N.J.) |
8-May-25 |
Hon. Christine P. O’Hearn |
Jakafi®
(ruxolitinib tablets) |
7,598,257
8,415,362
8,722,693
8,822,481
8,829,013 |
| Novartis Pharms. Corp. v. Lupin Ltd., 25-0578 (D. Del.) |
9-May-25 |
Hon. John F. Murphy |
Mayzent®
(siponimod tablets) |
8,492,441
11,944,602 |
| United Therapeutics Corp. v. Liquidia Techs., Inc., 25-0368 (M.D.N.C.) |
9-May-25 |
Hon. Thomas D. Schroeder |
Yutrepia®
(treprostinil inhalation powder) |
11,357,782 |
| Novartis Pharms. Corp. v. Dr. Reddy’s Labs., Ltd., 25-4282 (D.N.J.) |
15-May-25 |
Hon. Renee Marie Bumb |
Mayzent®
(siponimod tablets) |
8,492,441
11,944,602 |
| American Regent, Inc. v. BPI Labs, LLC, 25-4439 (D.N.J.) |
16-May-25 |
Hon. Brian R. Martinotti |
Selenious Acid |
11,998,565
12,150,957 |
| Pfizer Inc. v. Somerset Therapeutics LLC, 25-0617 (D. Del.) |
16-May-25 |
Hon. Colm F. Connolly |
Xeljanz®
(tofacitinib tablets) |
RE41,783 |
| AbbVie Inc. v. Hetero Labs Ltd., 25-0625 (D. Del.) |
19-May-25 |
Hon. Jennifer L. Hall |
Orilissa®
(elagolix sodium tablets) |
12,102,637 |
| Pfizer Inc. v. Macleods Pharms. Ltd., 25-0632 (D. Del.) |
21-May-25 |
Hon. Colm F. Connolly |
Xeljanz®
(tofacitinib tablets) |
RE41,783 |
| Bayer Pharma AG v. Aurobindo Pharma Ltd., 25-0631 (D. Del.) |
21-May-25 |
Hon. Richard G. Andrews |
Xarelto®
(rivaroxaban tablets) |
10,828,310 |
| Aveo Pharms., Inc. v. Hetero USA Inc., 25-0639 (D. Del.) |
23-May-25 |
Hon. Maryellen Noreika |
Fotivda®
(tivozanib HCl capsules) |
11,504,365 |
| Novartis Pharms. Corp. v. Zenara Pharma Private Ltd., 25-0644 (D. Del.) |
23-May-25 |
Hon. Gregory B. Williams |
Promacta®
(eltrombopag olamine tablets) |
8,828,430 |
| Incyte Corp. v. Padagis Israel Pharms. Ltd., 25-5380 (D.N.J.) |
23-May-25 |
Hon. Madeline Cox Arleo |
Opzelura®
(ruxolitinib cream) |
12,226,419 |
| Otsuka America Pharm., Inc. v. Hetero Labs Ltd., 25-0647 (D. Del.) |
27-May-25 |
Hon. Gregory B. Williams |
Nuedexta®
(dextromethorphan hydrobromide / quinidine sulfate capsules) |
7,659,282 |
| Fennec Pharms. Inc. v. Cipla Ltd., 25-5709 (D.N.J.) |
27-May-25 |
Hon. Jamel K. Semper |
Pedmark®
(sodium thiosulfate injection) |
12,311,026 |
| Boehringer Ingelheim Pharms. Inc. v. Granules India Ltd., 25-0663 (D. Del.) |
29-May-25 |
Hon. Colm F. Connolly |
Jardiance®
(empagliflozin tablets) |
9,949,998
10,258,637
11,090,323
11,833,166 |
| Celgene Corp. v. USV Private Ltd., 25-6320 (D.N.J) |
30-May-25 |
Hon. Esther Salas |
Pomalyst®
(pomalidomide capsules) |
8,828,427
9,993,467
10,555,939 |
| Incyte Corp. v. Taro Pharms. Inc., 25-7243 (D.N.J.) |
4-Jun-25 |
Hon. Madeline Cox Arleo |
Opzelura®
(ruxolitinib cream) |
12,226,419 |
| Bayer Pharma AG v. Apotex Inc., 25-0694 (D. Del.) |
5-Jun-25 |
Hon. Richard G. Andrews |
Xarelto®
(rivaroxaban tablets) |
10,828,310 |
| American Regent, Inc. v. BPI Labs, LLC, 25-1470 (M.D. Fla.) |
6-Jun-25 |
Hon. William F. Jung |
Selenious Acid |
11,998,565
12,150,957 |
| Bayer Pharma AG v. Macleods Pharms. Ltd., 25-0719 (D. Del.) |
9-Jun-25 |
Hon. Richard G. Andrews |
Xarelto®
(rivaroxaban tablets) |
10,828,310 |
| Salix Pharms., Inc. v. Alkem Labs. Ltd., 25-9344 (D.N.J.) |
10-Jun-25 |
Hon. John F. Murphy |
Xifaxan®
(rifaximin tablets) |
11,779,571
11,564,912
8,193,196 |
| United Therapeutics Corp. v. Actelion Pharms., Ltd., IPR2025-01139 (PTAB) |
10-Jun-25 |
N/A |
Opsumit®
(macitentan tablets)
Opsynvi®
(macitentan / tadalafil tablets) |
8,268,847 |
| Aveo Pharms., Inc. v. Glenmark Pharms. Ltd., 25-0735 (D. Del.) |
13-Jun-25 |
Hon. Maryellen Noreika |
Fotivda®
(tivozanib HCl capsules) |
11,504,365
7,166,722 |
| Braintree Labs., Inc. v. Appco Pharma LLC, 25-10876 (D.N.J.) |
13-Jun-25 |
Hon. Christine P. O’Hearn |
Sutab®
(sodium sulfate / magnesium sulfate /
potassium chloride osmotic laxative tablets) |
10,143,656
11,033,498
11,382,864
11,638,697 |
| Pfizer Inc. v. Orient Pharma Co., Ltd., 25-0743 (D. Del.) |
16-Jun-25 |
Hon. Gregory B. Williams |
Xeljanz® XR
(tofacitinib citrate extended-release tablets) |
9,937,181
10,639,309
11,253,523 |
| Bayer Pharma AG v. Alembic Pharms. Ltd., 25-0753 (D. Del.) |
18-Jun-25 |
Hon. Richard G. Andrews |
Xarelto®
(rivaroxaban tablets) |
10,828,310 |
| Bayer Pharma AG v. Hetero Labs Ltd., 25-0754 (D. Del.) |
18-Jun-25 |
Hon. Richard G. Andrews |
Xarelto®
(rivaroxaban tablets) |
10,828,310 |
| Aragon Pharms., Inc. v. Hetero Labs Ltd. Unit V., 25-11924 (D.N.J.) |
18-Jun-25 |
Hon. Stanley R. Chesler |
Erleada®
(apalutamidetablets) |
8,445,507
8,802,689
9,388,159
9,987,261
9,481,663
9,884,054
RE49,353
10,849,888
10,702,508
11,963,952 |
| American Regent, Inc. v. Endo Operations Ltd., 25-11945 (D.N.J.) |
18-Jun-25 |
Hon. Brian R. Martinotti |
Tralement®
(trace elements zinc sulfate / cupric sulfate /
manganese sulfate / selenious acid injection) |
11,786,548
11,975,022
11,998,565
12,150,956
12,150,957 |
| Indivior Inc. v. Lupin Inc., 25-0757 (D. Del.) |
20-Jun-25 |
Hon. Jennifer L. Hall |
Opvee®
(nalmefene Nasal spray) |
11,458,091
12,290,596 |
| Amneal Pharms. LLC v. Sandoz Inc., 25-11981 (D.N.J.) |
20-Jun-25 |
Hon. Georgette Castner |
Crexont®
(carbidopa / levodopa extended-release capsules) |
12,201,596
12,263,148
12,263,149
12,274,793 |
| Pfizer Inc. v. Apotex Inc., 25-0765 (D. Del.) |
20-Jun-25 |
Hon. Colm F. Connolly |
Ibrance®
(palbociclib tablets) |
RE47,739 |
| Novo Nordisk Inc. v. Sun Pharm. Indus. Ltd., 25-0767 (D. Del.) |
20-Jun-25 |
Hon. Colm F. Connolly |
Wegovy®
(semaglutide injection) |
12,214,017 |
| Pfizer Inc. v. Apotex Inc., 25-0775 (D. Del.) |
23-Jun-25 |
Hon. Colm F. Connolly |
Xeljanz® XR
(tofacitinib extended-release tablets) |
RE41,783 |
| Braintree Labs., Inc. v. Alkem Labs. Ltd., 25-12118 (D.N.J.) |
25-Jun-25 |
Hon. Christine P. O’Hearn |
Sutab®
(sodium sulfate / magnesium sulfate /
potassium chloride osmotic laxative tablets) |
10,143,656
11,033,498
11,382,864
11,638,697 |
| American Regent, Inc. v. Amneal Pharms. of NY, LLC, 25-12169 (D.N.J.) |
26-Jun-25 |
Hon. Brian R. Martinotti |
Multrys®
(trace elements injection) |
11,786,548
11,975,022
11,998,565
12,150,956 |
| Supernus Pharms., Inc. v. Appco Pharma LLC, 25-12183 (D.N.J.) |
26-Jun-25 |
Hon. Michael E. Farbiarz |
Qelbree®
(viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Supernus Pharms., Inc. v. Apotex Inc., 25-12184 (D.N.J.) |
26-Jun-25 |
Hon. Michael E. Farbiarz |
Qelbree®
(viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Supernus Pharms., Inc. v. Aurobindo Pharma Ltd., 25-12186 (D.N.J.) |
26-Jun-25 |
Hon. Michael E. Farbiarz |
Qelbree®
(viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Supernus Pharms., Inc. v. Zydus Lifesciences Global FZE, 25-12188 (D.N.J.) |
26-Jun-25 |
Hon. Michael E. Farbiarz |
Qelbree®
(viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338 |
| Novartis Pharms. Corp. v. Eugia Pharma Specialities Ltd., 25-800 (D. Del.) |
27-Jun-25 |
Hon. Gregory B. Williams |
Tasigna®
(nilotinib HCl capsules) |
8,163,904
8,293,756
8,389,537
8,415,363
8,501,760
9,061,029 |
| Eli Lilly & Co. v. Qilu Pharm. Co., Ltd., 25-12347 (D.N.J.) |
30-Jun-25 |
Hon. Evelyn Padin |
Reyvow®
(lasmiditan tablets) |
12,257,246 |
